Publishing, congresses and scientific exchange still matter. But they’re no longer necessarily where discovery starts.

In this episode of The Grateful Med, we sit down with Alyson Hagert, President of Social Media at Real Chemistry, to talk about how social is reshaping medical affairs. We dig into where HCPs actually encounter new information today, how they use social when time is tight and why simple, credible content often outperforms anything flashy.

It’s a conversation about changing behaviors, not chasing platforms. And about what it means to design medical communications for the way science really moves today.

Creativity in pharma isn't about breaking rules. It's about giving ideas enough air before we wrap them in structure. This episode explores how early internal skepticism shrinks ambition long before compliance ever does, and why exploration, guardrails and scientific rigor make creative work sharper, clearer and easier to defend.

If you want ideas that move through review with purpose without losing their edge, this conversation is for you.